Brief: Onxeo Says New Preclinical Data Confirm Antitumoral Properties Of AsiDNA

Valerio Therapeutics SA

08/12/2021 17:12

Dec 8 (Reuters) - Onxeo SA  ALONX.PA :
    * NEW PRECLINICAL DATA CONFIRM ABILITY OF ASIDNA™ TO TACKLE
DRUG-TOLERANT PERSISTER CELLS AND PREVENT TUMOR RESISTANCE IN
SEVERAL COMBINATION TREATMENTS

Source text for Eikon:  ID:nBw8hB01Ta 
Further company coverage:  ALONX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))